Ebp2p, yeast homologue of a human protein that interacts with Epstein-Barr virus Nuclear Antigen 1, is required for pre-rRNA processing and ribosomal subunit assembly

被引:58
|
作者
Tsujii, R
Miyoshi, K
Tsuno, A
Matsui, Y
Toh-e, A
Miyakawa, T
Mizuta, K
机构
[1] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398527, Japan
[2] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan
关键词
D O I
10.1046/j.1365-2443.2000.00346.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: A defect in the secretory pathway causes the transcriptional repression of both rRNA and ribosomal protein genes in Saccharomyces cerevisiae, suggesting a coupling of ribosome synthesis and plasma membrane synthesis. Rrs1p, an essential nuclear protein, is required for the secretory response. Results: EBP2, encoding the yeast homologue of a human protein that interacts with Epstein-Barr virus Nuclear Antigen 1, was cloned in a two-hybrid screen using RRS1 as a bait. The rrs1-1 mutation, which produces Rrs1p without the C-terminal half and causes a defect in the secretory response, almost abolished the interaction with Ebp2p. Ebp2p is essential for growth and is mainly localized in the nucleolus. The effects of Ebp2p depletion on ribosome biogenesis is quite similar to that of Rrs1p depletion; in the Ebp2p-depleted cells, the rate of pre-rRNA processing is slower, and significantly less mature 25S rRNA is produced compared to those in wild-type cells. The polysome pattern indicates that Ebp2p-depletion causes a decrease of 80S monosomes and polysomes, an accumulation of 40S subunits, and the appearance of half-mer polysomes. Conclusions: Ebp2p is required for the maturation of 25S rRNA and 60S subunit assembly. Ebp2p may be one of the target proteins of Rrs1p for executing the signal to regulate ribosome biogenesis.
引用
收藏
页码:543 / 553
页数:11
相关论文
共 48 条
  • [41] Co-expression of Epstein-Barr virus latent membrane protein 1, bcl-2, bcl-xL, p21Cip1 and p53 genes in human lymphoepitihelial carcinoma
    Kocki, J
    Jarosz, B
    Constantinou, M
    Korszen-Pilecka, I
    Pilecki, M
    Antosz, H
    Staroslawska, E
    Korobowicz, E
    Kaluzewski, B
    Wojcierowski, J
    BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY, 2002, : 33 - 37
  • [42] Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): Ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation
    Yokoyama, A
    Tanaka, M
    Matsuda, G
    Kato, K
    Kanamori, M
    Kawasaki, H
    Hirano, H
    Kitabayashi, I
    Ohki, M
    Hirai, K
    Kawaguchi, Y
    JOURNAL OF VIROLOGY, 2001, 75 (11) : 5119 - 5128
  • [43] Physical interaction of Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) with human oestrogen-related receptor 1 (hERR1): hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBV-induced B-cell immortalization
    Igarashi, M
    Kawaguchi, Y
    Hirai, K
    Mizuno, F
    JOURNAL OF GENERAL VIROLOGY, 2003, 84 : 319 - 327
  • [44] The antibody 2B4 directed against the Epstein-Barr virus (EBV)-encoded nuclear antigen I (EBNA1) detects MAGE-4:: implications for studies on the EBV association of human cancers
    Hennard, C.
    Pfuhl, T.
    Buettner, M.
    Becker, K-F
    Knofel, T.
    Middeldorp, J.
    Krernmer, E.
    Niedobitek, G.
    Grasser, F. A.
    JOURNAL OF PATHOLOGY, 2006, 209 (04): : 430 - 435
  • [45] Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1
    Matsuda, G
    Nakajima, K
    Kawaguchi, Y
    Yamanashi, Y
    Hirai, K
    MICROBIOLOGY AND IMMUNOLOGY, 2003, 47 (01) : 91 - 99
  • [46] Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway
    Eliopoulos, AG
    Caamano, JH
    Flavell, J
    Reynolds, GM
    Murray, PG
    Poyet, JL
    Young, LS
    ONCOGENE, 2003, 22 (48) : 7557 - 7569
  • [47] High-Activity P-Glycoprotein, Multidrug Resistance Protein 2, and Breast Cancer Resistance Protein Membrane Vesicles Prepared from Transiently Transfected Human Embryonic Kidney 293-Epstein-Barr Virus Nuclear Antigen Cells
    Karlsson, Johan E.
    Heddle, Catherine
    Rozkov, Aleksei
    Rotticci-Mulder, Joke
    Tuvesson, Ola
    Hilgendorf, Constanze
    Andersson, Tommy B.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (04) : 705 - 714
  • [48] STABLE TRANSFECTION OF EPSTEIN-BARR VIRUS (EBV) NUCLEAR ANTIGEN-2 IN LYMPHOMA-CELLS CONTAINING THE EBV-P3HR1 GENOME INDUCES EXPRESSION OF B-CELL ACTIVATION MOLECULES CD21 AND CD23
    CORDIER, M
    CALENDER, A
    BILLAUD, M
    ZIMBER, U
    ROUSSELET, G
    PAVLISH, O
    BANCHEREAU, J
    TURSZ, T
    BORNKAMM, G
    LENOIR, GM
    JOURNAL OF VIROLOGY, 1990, 64 (03) : 1002 - 1013